Abnormal levels of brain metabolites may mediate cognitive impairment in stroke-free patients with cerebrovascular risk factors

Age and Ageing

Volumn 43, Issue 5, 2014, Pages 681-686

  Sun, Dong ^a   Zhang, Junjian ^a   Fan, Yuanteng ^a   Liu, Xuan ^a   Gao, Yongzhe ^a   Wu, Guangyao ^a   Yan, Yatao ^a   Zeng, Junjie ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Brain metabolites; Cognitive impairment; Framingham stroke risk profile

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID; BIOLOGICAL MARKER;

AGED; ARTICLE; BRAIN METABOLISM; CEREBROVASCULAR RISK FACTOR; COGNITIVE DEFECT; EXECUTIVE FUNCTION; FEMALE; FRAMINGHAM RISK SCORE; HIGH RISK POPULATION; HIPPOCAMPUS; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PREFRONTAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; RECALL; RISK FACTOR; WORKING MEMORY; CEREBROVASCULAR DISORDERS; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDY; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; PSYCHOLOGY; SHORT TERM MEMORY;

AGED; BIOMARKERS; CEREBROVASCULAR DISORDERS; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; EXECUTIVE FUNCTION; FEMALE; GLUTAMIC ACID; GLUTAMINE; HIPPOCAMPUS; HUMANS; MALE; MEMORY, SHORT-TERM; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PREFRONTAL CORTEX; PROTON MAGNETIC RESONANCE SPECTROSCOPY; RISK FACTORS;

EID: 84906853489     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afu027     Document Type: Article

References (30)

1. Yang W, Lu J, Weng J et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010; 362: 1090-101.
2. Ma YQ, Mei WH, Yin P, Yang XH, Rastegar SK, Yan JD. Prevalence of hypertension in Chinese cities: a meta-analysis of published studies. PLoS ONE 2013; 8: e58302.
3. Unverzagt FW, McClure LA, Wadley VG et al. Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology 2011; 77: 1729-36.
4. Novak V, Last D, Alsop DC et al. Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care 2006; 29: 1529-34.
5. Seshadri S, Wolf PA, Beiser A et al. Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring study. Neurology 2004; 63: 1591-9.
6. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM. Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension. Stroke. 2008; 39: 349-54.
7. Gallinat J, Schubert F, Bruhl R et al. Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex. NeuroImage 2010; 49: 767-71.
8. Bleich S, Romer K, Wiltfang J, Kornhuber J. Glutamate and the glutamate receptor system: a target for drug action. Int J Geriatr Psych. 2003; 18(Suppl. 1): S33-40.
9. Maddock RJ, Casazza GA, Buonocore MH, Tanase C. Vigorous exercise increases brain lactate and Glx (glutamate +glutamine): a dynamic 1H-MRS study. NeuroImage 2011; 57: 1324-30.
10. Cecil KM, Jones BV. Magnetic resonance spectroscopy of the pediatric brain. Top Magn Reson Imaging 2001; 12: 435-52.
11. Kantarci K. Proton MRS in mild cognitive impairment. J Magn Reson Imaging 2013; 37: 770-7.
12. Sahin I, Alkan A, Keskin L et al. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J Diab Complic 2008; 22: 254-60.
13. Garcia-Garcia HM, Serruys PW, Mintz GS et al. Synergistic effect of cardiovascular risk factors on necrotic core in coronary arteries: a report from the global intravascular radiofrequency data analysis registry. J Am Coll Cardiol Img 2009; 2: 629-36.
14. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991; 22: 312-8.
15. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med. 1993; 30: 424-37.
16. Choi CG, Frahm J. Localized proton MRS of the human hippocampus: metabolite concentrations and relaxation times. Magn Reson Med. 1999; 41: 204-7.
17. Dregan A, Stewart R, Gulliford MC. Cardiovascular risk factors and cognitive decline in adults aged 50 and over: a population-based cohort study. Age Ageing. 2013; 42: 338-45.
18. Joosten H, van Eersel ME, Gansevoort RT, Bilo HJ, Slaets JP, Izaks GJ. Cardiovascular risk profile and cognitive function in young, middle-aged, and elderly subjects. Stroke. 2013; 44: 1543-9.
19. Knopman DS, Mosley TH, Catellier DJ, Coker LH. Atherosclerosis Risk in Communities Study Brain MRIS. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimers Dement. 2009; 5: 207-14.
20. Budson AE. Understanding memory dysfunction. The Neurologist 2009; 15: 71-9.
21. Glodzik L, Rusinek H, Brys M et al. Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia. J Cerebr Blood Flow Metab 2011; 31: 671-9.
22. Reed BR, Marchant NL, Jagust WJ, DeCarli CC, Mack W, Chui HC. Coronary risk correlates with cerebral amyloid deposition. Neurobiol Aging 2012; 33: 1979-87.
23. Jeerakathil T, Wolf PA, Beiser A et al. Stroke risk profile predicts white matter hyperintensity volume: the Framingham study. Stroke. 2004; 35: 1857-61.
24. Au R, Massaro JM, Wolf PA et al. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol. 2006; 63: 246-50.
25. Rupsingh R, Borrie M, Smith M, Wells JL, Bartha R. Reduced hippocampal glutamate in Alzheimer disease. Neurobiol Aging 2011; 32: 802-10.
26. Westhoff TH, Schubert F, Wirth C et al. The impact of blood pressure on hippocampal glutamate and mnestic function. J Hum Hypertens 2011; 25: 256-61.
27. Cosentino F, Battista R, Scuteri A et al. Impact of fasting glycemia and regional cerebral perfusion in diabetic subjects: a study with technetium-99m-ethyl cysteinate dimer single photon emission computed tomography. Stroke. 2009; 40: 306-8.
28. Chrissobolis S, Miller AA, Drummond GR, Kemp-Harper BKSobey CG. Oxidative stress and endothelial dysfunction in cerebrovascular disease. Front Biosci 2011; 16: 1733-45.
29. Matos M, Augusto E, Oliveira CR, Agostinho P. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogenactivated protein kinase cascades. Neuroscience 2008; 156: 898-910.
30. Garcia Santos JM, Fuentes LJ, Vidal JB et al. Posterior paralimbic and frontal metabolite impairments in asymptomatic hypertension with different treatment outcomes. Hypertens Res. 2010; 33: 67-75.